158 related articles for article (PubMed ID: 10853747)
21. A review on radiogenic Lhermitte's sign.
Esik O; Csere T; Stefanits K; Lengyel Z; Sáfrány G; Vönöczky K; Lengyel E; Nemeskéri C; Repa I; Trón L
Pathol Oncol Res; 2003; 9(2):115-20. PubMed ID: 12858217
[TBL] [Abstract][Full Text] [Related]
22. Chronic progressive radiation myelopathy. Its clinical aspects and differential diagnosis.
Reagan TJ; Thomas JE; Colby MY
JAMA; 1968 Jan; 203(2):106-10. PubMed ID: 5694057
[No Abstract] [Full Text] [Related]
23. Identifying risk factors for L'Hermitte's sign after IMRT for head and neck cancer.
Laidley HM; Noble DJ; Barnett GC; Forman JR; Bates AM; Benson RJ; Jefferies SJ; Jena R; Burnet NG
Radiat Oncol; 2018 May; 13(1):84. PubMed ID: 29728105
[TBL] [Abstract][Full Text] [Related]
24. Lhermitte's sign as a presenting symptom of primary spinal cord tumor.
Newton HB; Rea GL
J Neurooncol; 1996 Aug; 29(2):183-8. PubMed ID: 8858524
[TBL] [Abstract][Full Text] [Related]
25. Lhermitte's Sign Developing after IMRT for Head and Neck Cancer.
Lim DC; Gagnon PJ; Meranvil S; Kaurin D; Lipp L; Holland JM
Int J Otolaryngol; 2010; 2010():907960. PubMed ID: 20628529
[TBL] [Abstract][Full Text] [Related]
26. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
Lu H; Yao M; Tan H
Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
[TBL] [Abstract][Full Text] [Related]
27. Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell Carcinoma.
Quan K; Xu KM; Zhang Y; Clump DA; Flickinger JC; Lalonde R; Burton SA; Heron DE
Semin Radiat Oncol; 2016 Apr; 26(2):112-9. PubMed ID: 27000507
[TBL] [Abstract][Full Text] [Related]
28. Low dose rate irradiation of advanced head and neck cancers: present status.
Pierquin BM; Mueller WK; Baillet F
Int J Radiat Oncol Biol Phys; 1978; 4(7-8):565-72. PubMed ID: 711529
[No Abstract] [Full Text] [Related]
29. Alternative models for estimating the radiotherapy retreatment dose for the spinal cord.
Jones B; Hopewell JW
Int J Radiat Biol; 2014 Sep; 90(9):731-41. PubMed ID: 24894515
[TBL] [Abstract][Full Text] [Related]
30. A comparison of myelopathy associated with megavoltage irradiation and remote cancer.
Brown WJ; Kagan AR
Bull Los Angeles Neurol Soc; 1978 Mar; 43(1):12-26. PubMed ID: 215257
[TBL] [Abstract][Full Text] [Related]
31. Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy.
Chen CC; Lee CC; Mah D; Sharma R; Landau E; Garg M; Wu A
Med Dosim; 2011; 36(1):21-7. PubMed ID: 20202815
[TBL] [Abstract][Full Text] [Related]
32. Radiation myelopathy in children.
Sundaresan N; Gutierrez FA; Larsen MB
Ann Neurol; 1978 Jul; 4(1):47-50. PubMed ID: 697325
[TBL] [Abstract][Full Text] [Related]
33. Radiation myelopathy of the cervical spinal cord: time, dose and volume factors.
Abbatucci JS; Delozier T; Quint R; Roussel A; Brune D
Int J Radiat Oncol Biol Phys; 1978; 4(3-4):239-48. PubMed ID: 640895
[No Abstract] [Full Text] [Related]
34. Delayed onset of Lhermitte's sign following head and/or neck injuries. Report of four cases.
Chan RC; Steinbok P
J Neurosurg; 1984 Mar; 60(3):609-12. PubMed ID: 6699706
[TBL] [Abstract][Full Text] [Related]
35. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
[TBL] [Abstract][Full Text] [Related]
36. [Post-radiotherapy brachial plexopathy and cervical myelopathy].
Iranzo A; Martí-Fàbregas J; Roig C; Pradas J
Neurologia; 1998; 13(6):304-6. PubMed ID: 9734205
[TBL] [Abstract][Full Text] [Related]
37. Regional cumulative maximum dose to the spinal cord in head-and-neck cancer: considerations for re-irradiation.
Stoiber EM; Schwarz M; Debus J; Huber PE; Bendl R; Giske K
Radiother Oncol; 2013 Jan; 106(1):96-100. PubMed ID: 23260860
[TBL] [Abstract][Full Text] [Related]
38. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival.
Coderre JA; Morris GM; Micca PL; Hopewell JW; Verhagen I; Kleiboer BJ; van der Kogel AJ
Radiat Res; 2006 Sep; 166(3):495-503. PubMed ID: 16953668
[TBL] [Abstract][Full Text] [Related]
39. Weekly kilovoltage cone-beam computed tomography for detection of dose discrepancies during (chemo)radiotherapy for head and neck cancer.
Hermans BC; Persoon LC; Podesta M; Hoebers FJ; Verhaegen F; Troost EG
Acta Oncol; 2015; 54(9):1483-9. PubMed ID: 26219958
[TBL] [Abstract][Full Text] [Related]
40. [Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus].
Boisselier P; Racadot S; Thariat J; Graff P; Pointreau Y
Cancer Radiother; 2016 Oct; 20(6-7):459-66. PubMed ID: 27614529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
